Oligonucleotide synthesis market to reach $16.7 billion by 2027
European Pharmaceutical Review
DECEMBER 9, 2022
billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The data indicated primers are anticipated to show the highest growth in the synthesised oligos market over the forecast period. Tag Copenhagen A/S (Denmark).
Let's personalize your content